Option chain shows key data for Calidi Biotherapeutics's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for Calidi Biotherapeutics.

Calidi Biotherapeutics (AMEX:CLDI) Stock, Option Chain

Calidi Biotherapeutics

Calidi Biotherapeutics, Inc. Common Stock

Overview

News

Earnings

Analyst Ratings

Insider Trades

Short Interest

Stock Report

Calidi Biotherapeutics Inc is a clinical-stage immuno-oncology company with technology designed to arm the immune system to fight cancer. The Company's stem cell-based platforms utilize potent allogeneic stem cells capable of carrying payloads of oncolytic viruses for use in a many oncology indications, including high-grade gliomas and solid tumors. Its products include CLD-101 for Recurrent HGG; CLD-201 for Solid Tumors, and CLD-400 for certain lung cancer and Metastatic Solid Tumors. In addition to its pipeline products, the Company's is also engaged in discovery research of CLD-301 (AAA) for tumor Indications.

Comments

Calidi Biotherapeutics Option Chain

No option chain data available. Please try again later